跳至主要内容
临床试验/ISRCTN44653506
ISRCTN44653506已完成未知

Prophylaxis of thromboembolism in critically ill patients using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone: a multicenter randomized controlled trial

King Abdullah International Medical Research Center0 个研究点目标入组 2,003 人开始时间: 2013年10月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
2,003

研究概览

简要总结

2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/27488380 protocol 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30779530 results 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/32095845 sub-study results (added 26/02/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35595804/ Secondary analysis (added 23/05/2022) 2023 Other publications in https://pubmed.ncbi.nlm.nih.gov/36869382/ Post hoc analysis (added 06/03/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • All patients (male + female) admitted to ICU will be screened for eligibility
  • 1. Medical-Surgical ICU patients >14 years old
  • 2. Weight > 45 kg
  • 3. Expected ICU LOS> 72 hours
  • 4. Eligible for pharmacologic thromboprophylaxis with UFH and LMWH

排除标准

  • Exclusion criteria as of 04/04/2017:
  • 1. Patient treated with IPC for > 24 hours in this current ICU admission.
  • 2. Patient in the ICU> 48 hours.
  • 3. Patient treated with pharmacologic VTE prophylaxis with medications other than UFH or LMWH.
  • 4. Inability or contraindication to applying IPC to both legs or to obtain adequate ultrasound on the lower extremities
  • 4.1. Burns in the lower extremities, lacerations, active skin infection, & ischemic limb in the legs, large dressings at the site of IPC placement or in the thighs that prevent adequate ultrasounds
  • 4.2. Acute ischemia in the lower extremities
  • 4.3. Amputated foot or leg on one or two sides
  • 4.4. Compartment Syndrome
  • 4.5. Severe peripheral arterial disease
  • 4.6. Vein ligation, gangrene, recent vein grafts, and draining incisions
  • 4.7. Evidence of bone fracture in lower extremities
  • 4.8. Arterial lines in the dorsalis pedis artery
  • 5. Therapeutic dose of anticoagulation with UFH or LMWH
  • 6. Pregnancy
  • 7. Limitation of life support, life expectancy < 7 days or palliative care
  • 8. Allergy to the sleeves material
  • 9. Patients with Inferior Vena Cava (IVC) Filter
  • Eligible Non-Randomized Criteria
  • 1. Patient or substitute decision maker declines consent but agrees to minimal data set collection
  • 2. Unable to get consent within 48 hours of ICU admission
  • 3. ICU physician or other treating clinician declines consent
  • 4. Co-enrollment in trials with biologic interaction
  • Original exclusion criteria:
  • 1. Patient on IPC for > 24 hours in this current ICU admission
  • 2. Patient on pharmacologic prophylaxis with medications other than UFH or LMWH
  • 3. Inability or contraindication to applying IPC to both legs:
  • 3.1. Burns in the lower extremities, lacerations, active skin infection, & ischemic limb in the legs at the site of IPC placement
  • 3.2. Acute ischemia in the lower extremities
  • 3.3. Amputated foot or leg on one or two sides
  • 3.4. Compartment Syndrome
  • 3.5. Severe peripheral arterial disease
  • 3.6. Vein ligation, gangrene, recent vein grafts, and draining incisions
  • 3.7. Evidence of bone fracture in lower extremities
  • 4. The need for therapeutic anticoagulation
  • 5. Pregnancy
  • 6. Limitation of life support, life expectancy < 7 days or palliative care
  • 7. Allergy to the sleeves material

研究者

相似试验

The PREVENT trial: pneumatic compression for... | 临床试验